These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17959479)

  • 1. Legal and ethical issues in the regulation and development of engineering achievements in medical technology: a 2006 perspective.
    Malloy A
    Conf Proc IEEE Eng Med Biol Soc; 2006; Suppl():6660-2. PubMed ID: 17959479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Legal and ethical issues in the regulation and development of engineering achievements in medical technology. II.
    Bronzino JD; Flannery EJ; Wade M
    IEEE Eng Med Biol Mag; 1990; 9(2):53-7. PubMed ID: 18238337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical issues in the regulation and development of engineering achievements in medical technology-a regulatory perspective.
    Rahmoeller GA
    IEEE Eng Med Biol Mag; 1988; 7(2):94-5. PubMed ID: 18244066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Awareness of the role of science in the FDA regulatory submission process: a survey of the TERMIS-Americas membership.
    Johnson PC; Bertram TA; Carty NR; Hellman KB; Tawil BJ; Van Dyke M
    Tissue Eng Part A; 2014 Jun; 20(11-12):1565-82. PubMed ID: 24665855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Food and Drug Administration requirements for testing and approval of new radiopharmaceuticals.
    Harapanhalli RS
    Semin Nucl Med; 2010 Sep; 40(5):364-84. PubMed ID: 20674596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. US FDA perspective on the regulations of medical-grade polymers: cyanoacrylate polymer medical device tissue adhesives.
    Mattamal GJ
    Expert Rev Med Devices; 2008 Jan; 5(1):41-9. PubMed ID: 18095895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Legal and ethical issues in the regulation and development of engineering achievements in medical technology. I.
    Bronzino JD; Flannery EJ; Wade M
    IEEE Eng Med Biol Mag; 1990; 9(1):79-81. PubMed ID: 18238327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RU-486: legal and policy issues confronting the Food and Drug Administration.
    Muhl C
    J Leg Med; 1993 Jun; 14(2):319-47. PubMed ID: 8340714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
    Basile EM; Tolomeo D; Gluck E
    Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What physicians should know about the regulation of Obstetric and Gynecologic Medical Devices.
    Yin L
    J Reprod Med; 1983 Jan; 28(1):3-11. PubMed ID: 6834344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of Food and Drug Administration--approved medications for unlabeled (off-label) uses. The legal and ethical implications.
    Torres A
    Arch Dermatol; 1994 Jan; 130(1):32-6. PubMed ID: 8285737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future development of global regulations of Chinese herbal products.
    Fan TP; Deal G; Koo HL; Rees D; Sun H; Chen S; Dou JH; Makarov VG; Pozharitskaya ON; Shikov AN; Kim YS; Huang YT; Chang YS; Jia W; Dias A; Wong VC; Chan K
    J Ethnopharmacol; 2012 Apr; 140(3):568-86. PubMed ID: 22373513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The financing and regulation of medical devices in the United States.
    Sisk JE
    Med Prog Technol; 1982; 9(2-3):181-6. PubMed ID: 7162490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New drug and antibiotic regulations--FDA. Proposed rule.
    Fed Regist; 1982 Oct; 47(202):46622-66. PubMed ID: 10262075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No sisyphean task: how the FDA can regulate electronic cigarettes.
    Paradise J
    Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA medical device approval: things you didn't learn in medical school or residency.
    Buch B
    Am J Orthop (Belle Mead NJ); 2007 Aug; 36(8):407-12. PubMed ID: 17849025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA & digital mammography: why has FDA required full field digital mammography systems to be regulated as potentially dangerous devices for more than 10 years?
    Nields MW
    Acad Radiol; 2010 May; 17(5):652-7. PubMed ID: 20380981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug regulation and policy formulation.
    Nightingale SL
    Milbank Mem Fund Q Health Soc; 1981; 59(3):412-44. PubMed ID: 7024847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory perspectives on pharmacogenomics: a review of the literature on key issues faced by the United States Food and Drug Administration.
    Phillips KA; Van Bebber SL
    Med Care Res Rev; 2006 Jun; 63(3):301-26. PubMed ID: 16651395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The US Food and Drug Administration investigational device exemptions and clinical investigation of cardiovascular devices: information for the investigator.
    Pritchard WF; Abel DB; Karanian JW
    J Vasc Interv Radiol; 1999 Feb; 10(2 Pt 1):115-22. PubMed ID: 10082096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.